NO893764D0 - Fremgangsmaate til fremstilling av 1-((diarylmetoksy)alkyl)-pyrrolidiner og -piperidiner. - Google Patents

Fremgangsmaate til fremstilling av 1-((diarylmetoksy)alkyl)-pyrrolidiner og -piperidiner.

Info

Publication number
NO893764D0
NO893764D0 NO893764A NO893764A NO893764D0 NO 893764 D0 NO893764 D0 NO 893764D0 NO 893764 A NO893764 A NO 893764A NO 893764 A NO893764 A NO 893764A NO 893764 D0 NO893764 D0 NO 893764D0
Authority
NO
Norway
Prior art keywords
diarylmetoxy
pyrrolidines
piperidines
alkyl
procedure
Prior art date
Application number
NO893764A
Other languages
English (en)
Other versions
NO893764L (no
Inventor
Gerard Ferrand
Jacques Barbanton
Jean-Claude Depin
Gilles Chavernac
Original Assignee
Lipha
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lipha filed Critical Lipha
Publication of NO893764D0 publication Critical patent/NO893764D0/no
Publication of NO893764L publication Critical patent/NO893764L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/06Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with radicals, containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/10Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
    • C07D211/14Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • HELECTRICITY
    • H03ELECTRONIC CIRCUITRY
    • H03HIMPEDANCE NETWORKS, e.g. RESONANT CIRCUITS; RESONATORS
    • H03H7/00Multiple-port networks comprising only passive electrical elements as network components
    • H03H7/01Frequency selective two-port networks
    • H03H7/09Filters comprising mutual inductance

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyrrole Compounds (AREA)
NO89893764A 1988-09-23 1989-09-22 Fremgangsmaate til fremstilling av 1-((diarylmetoksy)alkyl)-pyrrolidiner og -piperidiner. NO893764L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8812430A FR2636946B1 (fr) 1988-09-23 1988-09-23 ((diarylmethoxy)alcoyl)-1 pyrrolidines et piperidines, procedes de preparation et medicaments les contenant

Publications (2)

Publication Number Publication Date
NO893764D0 true NO893764D0 (no) 1989-09-22
NO893764L NO893764L (no) 1990-03-26

Family

ID=9370298

Family Applications (1)

Application Number Title Priority Date Filing Date
NO89893764A NO893764L (no) 1988-09-23 1989-09-22 Fremgangsmaate til fremstilling av 1-((diarylmetoksy)alkyl)-pyrrolidiner og -piperidiner.

Country Status (25)

Country Link
US (1) US4957927A (no)
EP (1) EP0360685B1 (no)
JP (1) JPH02121964A (no)
AR (1) AR246255A1 (no)
AT (1) ATE101132T1 (no)
AU (1) AU617530B2 (no)
CA (1) CA1327364C (no)
CZ (1) CZ279282B6 (no)
DD (1) DD284875A5 (no)
DE (1) DE68912860T2 (no)
DK (1) DK468389A (no)
ES (1) ES2062071T3 (no)
FR (1) FR2636946B1 (no)
HU (1) HU208422B (no)
IE (1) IE63648B1 (no)
IL (1) IL91689A0 (no)
MA (1) MA21631A1 (no)
NO (1) NO893764L (no)
NZ (1) NZ230744A (no)
OA (1) OA09135A (no)
PT (1) PT91783B (no)
SU (1) SU1757462A3 (no)
TN (1) TNSN89103A1 (no)
YU (1) YU170189A (no)
ZA (1) ZA897212B (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX9100517A (es) * 1990-08-06 1992-04-01 Smith Kline French Lab Compuestos
MX9100513A (es) * 1990-08-06 1992-04-01 Smith Kline French Lab Compuestos
TW230771B (no) * 1990-08-09 1994-09-21 Sankyo Co
GB9113031D0 (en) * 1991-06-17 1991-08-07 Smithkline Beecham Plc Compounds
US5578639A (en) * 1994-07-01 1996-11-26 Warner-Lambert Company PLA2 inhibitors and their use for inhibition of intestinal cholesterol absorption
US6201124B1 (en) 1995-12-21 2001-03-13 Albany Molecular Research, Inc. Process for production of piperidine derivatives
US6153754A (en) * 1995-12-21 2000-11-28 Albany Molecular Research, Inc. Process for production of piperidine derivatives
US5747523A (en) * 1996-01-24 1998-05-05 Guilford Pharmaceuticals Inc. Substituted ethyl α,α-diarylmethyl ether derivatives
US6011035A (en) * 1998-06-30 2000-01-04 Neuromed Technologies Inc. Calcium channel blockers
US6946475B1 (en) 1999-04-07 2005-09-20 University Of Virginia Patent Foundation Anticancer calcium channel blockers
DE60011755T2 (de) * 1999-04-07 2005-06-30 The University Of Virginia Patent Foundation Calciumkanalblocker als antikrebsmittel
US6930186B2 (en) * 2001-06-13 2005-08-16 Teva Pharmacetical Industries Ltd. Process for the preparation of paroxetine substantially free of alkoxy impurities
US9427429B2 (en) 2010-03-01 2016-08-30 Tau Therapeutics Llc Cancer diagnosis and imaging

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1545094A (en) * 1976-12-14 1979-05-02 Gist Brocades Nv Piperazine derivatives

Also Published As

Publication number Publication date
SU1757462A3 (ru) 1992-08-23
AU4169089A (en) 1990-03-29
MA21631A1 (fr) 1990-04-01
JPH02121964A (ja) 1990-05-09
DE68912860T2 (de) 1994-08-11
IE893050L (en) 1990-03-23
PT91783B (pt) 1995-08-09
EP0360685A1 (fr) 1990-03-28
US4957927A (en) 1990-09-18
FR2636946A1 (fr) 1990-03-30
FR2636946B1 (fr) 1990-11-02
DK468389A (da) 1990-03-24
YU170189A (en) 1991-02-28
OA09135A (fr) 1991-10-31
DK468389D0 (da) 1989-09-22
PT91783A (pt) 1990-03-30
NO893764L (no) 1990-03-26
IE63648B1 (en) 1995-05-31
CZ279282B6 (cs) 1995-04-12
IL91689A0 (en) 1990-06-10
EP0360685B1 (fr) 1994-02-02
ES2062071T3 (es) 1994-12-16
NZ230744A (en) 1991-06-25
DD284875A5 (de) 1990-11-28
CZ540989A3 (en) 1994-11-16
AR246255A1 (es) 1994-07-29
ATE101132T1 (de) 1994-02-15
AU617530B2 (en) 1991-11-28
ZA897212B (en) 1991-03-27
HUT52049A (en) 1990-06-28
HU208422B (en) 1993-10-28
DE68912860D1 (de) 1994-03-17
CA1327364C (fr) 1994-03-01
TNSN89103A1 (fr) 1991-02-04

Similar Documents

Publication Publication Date Title
NO891226L (no) Fremgangsmaate til fremstilling av fotoherdede belegg.
NO894786L (no) Fremgangsmaate for fremstilling av propenonoksimetere.
NO165143C (no) Fremgangsmaate til fremstilling av hydrokloridet av fenyl-1-dietylaminokarbonyl-1-aminometyl-2-cyklopropan (z).
NO885454D0 (no) Fremgangsmaate for fremstilling av triklormonosilan.
NO894210L (no) Fremgangsmaate for fremstilling av kinolyloxazol-2-oner.
NO893764L (no) Fremgangsmaate til fremstilling av 1-((diarylmetoksy)alkyl)-pyrrolidiner og -piperidiner.
NO158136C (no) Fremgangsmaate til fremstilling av tiadiazolderivater.
NO894649D0 (no) Fremgangsmaate for fremstilling av (s)-alfa-ethyl-2-oxo-1-pyrrolidinacetamid.
NO861486L (no) Fremgangsmaate til fremstilling av fluorerte benzyltriazolforbindelser.
NO892204L (no) Fremgangsmaate for fremstilling av imidazokinoxalin-forbindelser.
NO905444L (no) Fremgangsmaate til fremstilling av oksazolderivater.
NO895032D0 (no) Fremgangsmaate for fremstilling av 2-benzotiazoliner.
NO890159L (no) Fremgangsmaate for fremstilling av 1-alkyl-5-nitroimidazoler.
NO883145D0 (no) Fremgangsmaate til fremstilling av tienoimidazolderivater.
NO901690D0 (no) Fremgangsmaate til fremstilling av substituerte azetidinylisotiazolpyridon-derivater.
NO895040L (no) Fremgangsmaate for fremstilling av polyhydroxybenzyloxypropanolaminer.
NO901422L (no) Fremgangsmaate for fremstilling av alfa-glucosidase-inhibitorer.
NO913720L (no) Fremgangsmaate for fremstilling av 1-((2s)-3-mercapto-methyl-1-oxopropyl)-l-prolin.
NO880106D0 (no) Fremgangsmaate til fremstilling av kalknitrogen.
NO883610D0 (no) Fremgangsmaate til fremstilling av substituerte tienoimidazol-derivater.
NO892813D0 (no) Fremgangsmaate til fremstilling av l-alanyl-l-prolin-derivater.
NO893357L (no) Fremgangsmaate for fremstilling av fenylalkylthiofener.
NO890819L (no) Fremgangsmaate for fremstilling av hydroksybenzaldehyder.
NO891004D0 (no) Fremgangsmaate til fremstilling av 7-oksomitosan-derivater.
NO870026D0 (no) Fremgangsmaate til fremstilling av trisubstituerte triazoler.